SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum
GLD 385.99+1.6%Nov 12 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: arun gera who wrote (176608)8/17/2021 9:41:12 AM
From: alanrs1 Recommendation

Recommended By
pak73

  Read Replies (2) of 217739
 
An mRNA treatment is not a vaccine in the traditional sense of the word, words are malleable and vaccine has been stretched in this case. Whatever one calls the fluid currently undergoing a widespread clinical trial, mistakes have been made injecting fluids into humans.

I hope it turns out to be a vaccine and not a therapy. Numbers out of Britain indicate T-cell levels drop off fairly quickly and there may be other longer term effects, still an open question. I hope the long term benefits far outweigh the risks of injecting this fluid. I hope the clinical trial is wildly successful.

I also hope that existing drugs are effective, the study out of hospitals in Argentina seem to indicate that Ivermectin is useful. I wonder about the obfuscation.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News